Wegovy is a semaglutide-based drug, approved specifically for weight loss, especially in people with obesity or overweight with comorbidities.
Full Definition:
Wegovy is a version of the substance semaglutide(same as in Ozempic), but in higher doses and officially approved for treatment of obesity. It's part of the class GLP-1 agonist, imitating a gut hormone that reduces appetite, slows digestion and regulates glycemic.
Official indications:
- Indicated for people with BMI ≥30or ≥27 with associated conditions (e.g. hypertension, diabetes, apnea).
- Administration:subcutaneous injection, 1 time per week.
- Doses:up to 2.4 mg/week.
Effects observed:
- Significant weight loss (average 10— 15% in clinical trials).
- Reducing blood sugar and systemic inflammation.
Caution:
Although effective, Wegovy is not a miracle solution. Its effectiveness depends on the adoption of a balanced lifestyle, and medical supervision is essentialto avoid side effects or improper use.
.svg)
